• OPEN AN ACCOUNT
Indian Indices
Sensex
79,310.01 2,008.61
( 2.60%)
Global Indices
Nasdaq
53,347.89 1,540.17
(2.97%)
Dow Jones
7,717.41 127.49
(1.68%)
Hang Seng
60,935.13 -1,253.50
(-2.02%)
Nikkei 225
10,776.27 -52.94
(-0.49%)
Forex
USD-INR
94.73 -0.07
(-0.07%)
EUR-INR
105.99 -0.12
(-0.11%)
GBP-INR
127.06 -0.04
(-0.03%)
JPY-INR
0.60 0.00
(-0.31%)

EQUITY - MARKET SCREENER

3B Blackbio DX Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
532067
INE994E01018
371.7143616
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
3BBLACKBIO
22.41
1141.71
EPS(TTM)
Face Value()
Div & Yield %
59.37
10
0.38
 

Orchid Pharma consolidated net profit rises 6.68% in the March 2026 quarter
May 26,2026
Net profit of Orchid Pharma rose 6.68% to Rs 23.78 crore in the quarter ended March 2026 as against Rs 22.29 crore during the previous quarter ended March 2025. Sales rose 0.05% to Rs 237.61 crore in the quarter ended March 2026 as against Rs 237.48 crore during the previous quarter ended March 2025.

For the full year,net profit declined 79.38% to Rs 20.55 crore in the year ended March 2026 as against Rs 99.66 crore during the previous year ended March 2025. Sales declined 12.00% to Rs 811.33 crore in the year ended March 2026 as against Rs 921.93 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales237.61237.48 0 811.33921.93 -12
OPM %11.3111.78 -5.0712.71 -
PBDT31.1127.97 11 63.04130.11 -52
PBT22.2519.09 17 27.5995.56 -71
NP23.7822.29 7 20.5599.66 -79